Document:

Exhibit 10.1

 

IRON MOUNTAIN INCORPORATED

Compensation Plan for Non-Employee Directors

 

	
Restatement   Date
    	
 
    	
As   of September 8, 2011
    
	
 
    	
 
    	
 
    
	
Eligibility
    	
 
    	
All   non-employee Directors
    
	
 
    	
 
    	
 
    
	
Annual   Board Retainer
    	
 
    	
$52,000   per year; paid in advance in quarterly installments
    
	
 
    	
 
    	
 
    
	
Annual   Committee Retainers
    	
 
    	
In   addition to the Annual Board Retainer, a $10,000 per year retainer for   members of the Audit Committee, Strategic Review Special Committee or CEO   Search Committee, a $7,500 per year retainer for members of the Compensation   Committee, and a $6,000 per year retainer for members of the Strategic   Planning and Capital Allocation or Nominating and Governance Committees; in   each case paid in advance in quarterly installments, provided, however, that   the Strategic Review Special Committee shall receive two installments of   $5,000 for each of the third and fourth quarters of 2011, paid in advance of   each such quarter.
    
	
 
    	
 
    	
 
    
	
Annual   Chair Retainers
    	
 
    	
In   addition to the Annual Board Retainer and any Annual Committee Retainers, a   $15,000 per year retainer for acting as Chair of the Audit Committee; a   $10,000 per year retainer for acting as Chair of the Compensation Committee,   an $8,000 per year retainer for acting as the Chair of the Strategic Planning   and Capital Allocation, CEO Search or Nominating and Governance Committees;   and a $25,000 per year retainer for acting as the Lead Independent Director;   in each case paid in advance in quarterly installments
    
	
 
    	
 
    	
 
    
	
Pro Rata Portion of Retainers
    	
 
    	
A   non-employee Director shall be entitled to retain the portion of the Annual,   Committee and Chair Retainers (as applicable) paid with respect to the   quarter in which he or she ceases to be a non-employee Director or serve on a   Committee or as a Chair or Lead Independent Director, but shall not be entitled   to any further portion of the Retainer(s)
    
	
 
    	
 
    	
 
    
	
Meeting   Expenses
    	
 
    	
Reimbursement   for all normal travel expenses to attend meetings; reimbursements due shall   be paid promptly after the end of each quarter, subject to timely receipt of   each director’s expense documentation
    
	
 
    	
 
    	
 
    
	
Group   Insurance Benefits
    	
 
    	
Iron   Mountain’s group medical and dental benefits (single or family) are available   to non-employee Directors, but they must pay the current employee   contribution rate in effect for such coverage; group life, AD&D, STD and   LTD coverage are not available to non-employee Directors
    
	
 
    	
 
    	
 
    
	
Amount   of Stock Grant
    	
 
    	
A   stock grant in the form of restricted stock units will be made of that number   of whole shares of Iron Mountain Incorporated common stock determined by   dividing $100,000 by the stock’s 
    

 

 

	
 
    	
 
    	
“fair   market value” (as determined under the Iron Mountain Incorporated 2002 Stock   Incentive Plan) on the date of grant
    
	
 
    	
 
    	
 
    
	
Timing   of Stock Grants
    	
 
    	
To   be made annually to all non-employee Directors as of the first Board meeting   following the annual meeting of stockholders; newly elected non-employee   Directors receive a pro-rated   grant on the date of their election or appointment to the Board
    
	
 
    	
 
    	
 
    
	
Vesting   of Stock Grants
    	
 
    	
100%   on the one year anniversary of grant (or, if earlier, the annual meeting of   stockholders that is closest to the one year anniversary)
    
	
 
    	
 
    	
 
    
	
Purchase   Price of Stock Grants
    	
 
    	
$0.01
    
	
 
    	
 
    	
 
    
	
Restrictions   on Transfer of Common Stock
    	
 
    	
None   once vested; prior to vesting transfer is subject to restrictions set forth   in the Iron Mountain Incorporated 2002 Stock Incentive Plan
    
	
 
    	
 
    	
 
    
	
SEC   Considerations
    	
 
    	
Grants   will generally be made under the Iron Mountain Incorporated 2002 Stock   Incentive Plan, the shares of each of which are registered on Form S-8;   insider trading restrictions and short-swing profit rules of the   Securities Exchange Act of 1934 apply
    
	
 
    	
 
    	
 
    
	
Taxation   of Stock Grants
    	
 
    	
Non-employee   Directors pay ordinary income tax (and SECA tax) at time of vesting, which   (except as described below) will also coincide with the delivery of shares,   on the fair market value of the shares on date of vesting; Iron Mountain   receives a corresponding tax deduction at that time
    
	
 
    	
 
    	
 
    
	
Election   to Defer Retainers
    	
 
    	
Non-employee   Directors may elect to defer some or all of their Retainer fees paid in cash   under the Iron Mountain Incorporated Directors Deferred Compensation Plan;   deferrals will be invested in phantom shares equal in value to Iron Mountain   common stock; deferral elections must be made by December 31 of the year   prior to the year in which the fees are earned (or within 30 days of becoming   eligible for the Plan); amounts will be subject to ordinary income tax when   distributed (at a time elected by the non-employee Director)
    
	
 
    	
 
    	
 
    
	
Election   to Defer Stock Grants
    	
 
    	
Non-employee   Directors may elect to defer some or all of their stock grant under the Iron   Mountain Incorporated Directors Deferred Compensation Plan; at vesting, the   Director’s account will be credited with a number of phantom shares equal to   the number of shares that would otherwise have been delivered; deferral   elections must be made by December 31 of the year prior to the year in   which the grant is made (or within 30 days of becoming eligible for the   Plan); amounts will be subject to ordinary income tax when distributed (at a   time elected by the non-employee Director)
    
	
 
    	
 
    	
 
    
	
Adopted:   September 8, 2011
    	
 
    	
 
    

 

2Exhibit 4.8

 

FIFTH SUPPLEMENTAL INDENTURE

 

This Fifth Supplemental Indenture, dated as of September 30, 2011 (this “Fifth  Supplemental Indenture”), is by and among 21st Century Oncology Services, Inc., a Delaware corporation (the “New Guarantor”), Radiation Therapy Services, Inc., a Florida corporation (the “Company,” which term includes its successors and assigns), each other then existing Guarantor under the Indenture referred to below (the “Guarantors”), and Wells Fargo Bank, National Association, as trustee (“Trustee”) under the Indenture referred to below.  Capitalized terms used and not defined herein shall have the same meanings given in the Indenture unless otherwise indicated.

 

W I T N E S S E T H:

 

WHEREAS, the Company, the Guarantors and the Trustee have heretofore executed and delivered an Indenture, dated as of April 20, 2010 (as supplemented by the First Supplemental Indenture, dated as of June 24, 2010, as further supplemented by the Second Supplemental Indenture, dated as of September 29, 2010, as further supplemented by the Third Supplemental Indenture, dated as of March 1, 2011, as further supplemented by the Fourth Supplemental Indenture, dated as of March 30, 2011 and as otherwise amended, supplemented, waived or modified, the “Indenture”), providing for the issuance of 9 7/8% Senior Subordinated Notes due 2017 of the Company (the “Notes”);

 

WHEREAS, pursuant to Section 10.03 of the Indenture, each Person that becomes obligated to provide a Guarantee pursuant to Section 4.16 of the Indenture must execute and deliver to the Trustee a supplemental indenture making such Person a party to the Indenture, along with a notation of such Guarantee in the form included as Exhibit E to the Indenture;

 

WHEREAS, pursuant to Section 4.16 of the Indenture, the Company will not permit any of its Restricted Subsidiaries (other than Foreign Subsidiaries) to guarantee Indebtedness under the Credit Agreement, unless such Restricted Subsidiary executes and delivers to the Trustee a supplemental indenture, providing a guarantee of payment of the Notes by such Restricted Subsidiary;

 

WHEREAS, the New Guarantor is a Restricted Subsidiary of the Company and has guaranteed or will guarantee Indebtedness under the Credit Agreement;

 

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee, the Company and the Guarantors are authorized to execute and deliver this Fifth Supplemental Indenture to amend the Indenture, without the consent of any Holder; and

 

WHEREAS, by entering into this Fifth Supplemental Indenture, the Company, the Guarantors and the Trustee have consented to amend the Indenture in accordance with the terms and conditions herein.

 

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the New Guarantor, the Guarantors, the Company and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

Section 1.               Agreement to be Bound.  The New Guarantor hereby becomes a party to the Indenture as a Guarantor and as such will have all of the rights and be subject to all of the obligations and agreements of a Guarantor under the Indenture.  The New Guarantor agrees to be bound by all of the provisions of the Indenture applicable to a Guarantor and to perform all of the obligations and agreements of a Guarantor under the Indenture.

 

Section 2.               Compliance with and Fulfillment of Condition of Sections 4.16 and 10.03.  The execution and delivery of this Fifth  Supplemental Indenture and the Guarantee by the New Guarantor  (along with such documentation relating thereto as the Trustee shall require) fulfills the obligations of the Company under Sections 4.16 and 10.03 of the Indenture.

 

Section 3.               Ratification of Indenture; Supplemental Indenture Part of Indenture; Trustee’s Disclaimer.  Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect.  This Fifth  Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby.  The Trustee makes no representation or warranty as to the validity or sufficiency of this Fifth  Supplemental Indenture.

 

Section 4.               Governing Law.  This Fifth Supplemental Indenture and the Notes shall be governed by and construed in accordance with the laws of the State of New York, as applied to contracts made and performed within the State of New York.

 

Section 5.               No Adverse Interpretation of Other Agreements.  This Fifth  Supplemental Indenture may not be used to interpret any other indenture, loan or debt agreement of the Company or its Subsidiaries (other than the Indenture).  No such indenture, loan or debt agreement may be used to interpret this Fifth  Supplemental Indenture or the Indenture.

 

Section 6.               Successors.  This Fifth  Supplemental Indenture shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

 

Section 7.               Separability.  Each provision of this Fifth  Supplemental Indenture shall be considered separable and if for any reason any provision which is not essential to the effectuation of the basic purpose of this Fifth  Supplemental Indenture or the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

Section 8.               Counterpart Originals.  The parties may sign multiple counterparts of this Fifth  Supplemental Indenture.  Each signed counterpart shall be deemed an original, but all of them together represent one and the same agreement.

 

Section 9.               Headings, etc.  The headings of the Sections of this Fifth  Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part of

 

 

this Fifth  Supplemental Indenture and shall in no way modify or restrict any of the terms or provisions hereof.

 

* * * * *

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Fifth  Supplemental Indenture to be duly executed as of the date first above written.

 

 

	
 
    	
 
    	
21ST   CENTURY ONCOLOGY SERVICES, INC., 
    
	
 
    	
 
    	
as   a Guarantor
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Bryan J. Carey
    
	
 
    	
 
    	
Name:   
    	
Bryan   J. Carey
    
	
 
    	
 
    	
Title:
    	
Interim   Vice President
    

 

 

	
 
    	
 
    	
RADIATION   THERAPY SERVICES, INC.
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Bryan J. Carey
    
	
 
    	
 
    	
Name:
    	
Bryan   J. Carey
    
	
 
    	
 
    	
Title:
    	
Interim   Senior Vice President and Chief
    
	
 
    	
 
    	
 
    	
Financial   Officer
    

 

 

	
 
    	
 
    	
21ST   CENTURY ONCOLOGY OF ALABAMA, LLC
    
	
 
    	
 
    	
ARIZONA RADIATION THERAPY MANAGEMENT SERVICES, INC.
    
	
 
    	
 
    	
CALIFORNIA RADIATION THERAPY MANAGEMENT SERVICES, INC.
    
	
 
    	
 
    	
21ST CENTURY ONCOLOGY OF JACKSONVILLE, LLC
    
	
 
    	
 
    	
DEVOTO CONSTRUCTION OF SOUTHWEST FLORIDA, INC.
    
	
 
    	
 
    	
RADIATION THERAPY SERVICES INTERNATIONAL, INC.
    
	
 
    	
 
    	
21ST CENTURY ONCOLOGY MANAGEMENT SERVICES, INC.
    
	
 
    	
 
    	
JACKSONVILLE RADIATION THERAPY SERVICES, LLC
    
	
 
    	
 
    	
FINANCIAL SERVICES OF SOUTHWEST FLORIDA, LLC
    
	
 
    	
 
    	
21ST CENTURY ONCOLOGY, LLC
    
	
 
    	
 
    	
21ST CENTURY ONCOLOGY OF HARFORD COUNTY MARYLAND,   LLC
    
	
 
    	
 
    	
BERLIN RADIATION THERAPY TREATMENT CENTER, LLC
    
	
 
    	
 
    	
21ST CENTURY ONCOLOGY OF PRINCE GEORGES COUNTY,   MARYLAND, LLC
    
	
 
    	
 
    	
MARYLAND RADIATION THERAPY MANAGEMENT SERVICES,   LLC
    
	
 
    	
 
    	
AMERICAN CONSOLIDATED TECHNOLOGIES, LLC
    
	
 
    	
 
    	
MICHIGAN RADIATION THERAPY MANAGEMENT SERVICES, INC.
    
	
 
    	
 
    	
NEVADA RADIATION THERAPY MANAGEMENT SERVICES, INCORPORATED
    
	
 
    	
 
    	
21ST CENTURY ONCOLOGY OF NEW JERSEY, INC.
    
	
 
    	
 
    	
NEW YORK RADIATION THERAPY MANAGEMENT SERVICES,   LLC
    
	
 
    	
 
    	
NORTH CAROLINA RADIATION THERAPY MANAGEMENT   SERVICES, LLC
    
	
 
    	
 
    	
21ST CENTURY ONCOLOGY OF SOUTH CAROLINA, LLC
    
	
 
    	
 
    	
WEST VIRGINIA RADIATION THERAPY SERVICES, INC.
    
	
 
    	
 
    	
PHOENIX   MANAGEMENT COMPANY, LLC
    
	
 
    	
 
    	
CAROLINA   REGIONAL CANCER CENTER, LLC
    
	
 
    	
 
    	
ATLANTIC   UROLOGY CLINICS, LLC,
    
	
 
    	
 
    	
as   Guarantors
    

 

	
 
    	
 
    	
By:
    	
/s/   Bryan J. Carey
    
	
 
    	
 
    	
 
    	
Name:
    	
Bryan   J. Carey
    
	
 
    	
 
    	
 
    	
Title:
    	
Interim   Vice President
    

 

 

	
 
    	
 
    	
21ST CENTURY ONCOLOGY OF PENNSYLVANIA, LLC
    
	
 
    	
 
    	
GETTYSBURG RADIATION, LLC
    
	
 
    	
 
    	
CAROLINA RADIATION AND CANCER TREATMENT CENTER,   LLC
    
	
 
    	
 
    	
RADIATION THERAPY SCHOOL FOR RADIATION THERAPY   TECHNOLOGY, INC.
    
	
 
    	
 
    	
NEW ENGLAND RADIATION THERAPY MANAGEMENT SERVICES,   INC.
    
	
 
    	
 
    	
DERM-RAD INVESTMENT COMPANY, LLC
    
	
 
    	
 
    	
AURORA TECHNOLOGY DEVELOPMENT, LLC,
    
	
 
    	
 
    	
as   Guarantors
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Bryan J. Carey
    
	
 
    	
 
    	
 
    	
Name:
    	
Bryan   J. Carey
    
	
 
    	
 
    	
 
    	
Title:
    	
Interim   Vice President
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
21ST CENTURY ONCOLOGY OF KENTUCKY, LLC, 
   as a Guarantor
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Bryan J. Carey
    
	
 
    	
 
    	
 
    	
Name:
    	
Bryan   J. Carey
    
	
 
    	
 
    	
 
    	
Title:
    	
Interim   Chief Financial Officer
    

 

 

	
 
    	
 
    	
RADIATION   THERAPY SERVICES HOLDINGS, INC., as a Guarantor
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Bryan J. Carey
    
	
 
    	
 
    	
Name:
    	
Bryan   J. Carey
    
	
 
    	
 
    	
Title:
    	
Interim   Senior Vice President and Chief
    
	
 
    	
 
    	
 
    	
Financial   Officer
    

 

 

	
 
    	
 
    	
WELLS   FARGO BANK, NATIONAL ASSOCIATION, 
   as Trustee
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
By:
    	
/s/   Stefan Victory
    
	
 
    	
 
    	
Name:
    	
Stefan   Victory
    
	
 
    	
 
    	
Title:
    	
Vice   President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00196-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00196-of-00352.parquet"}]]